Regulatory Scrutiny Tempers Healwell AI’s Growth Narrative
27.01.2026 - 03:05:04
A period of aggressive acquisitions and strategic refocusing defined 2025 for Healwell AI, dramatically reshaping its financial profile. However, the Canadian healthcare AI specialist now faces pressure from regulators to temper its ambitious growth projections. The central challenge lies in reconciling explosive revenue increases with persistent, significant losses, raising questions about the true path to sustainable profitability.
The company’s third-quarter 2025 results underscore this complex dynamic. Key figures reveal a stark contrast:
* Revenue from continuing operations reached CAD 30.4 million for the quarter.
* This represents a staggering 354% increase compared to Q3 2024.
* Adjusted EBITDA was positive at CAD 0.7 million.
* Despite this, the net loss from continuing operations Read more...
